Efficacy of sorafenib adjuvant therapy in northwestern Chinese patients with non-metastatic renal-cell carcinoma after nephrectomy: A multicenter retrospective study

Recent studies have confirmed the efficacy of sorafenib for patients with advanced renal cell carcinoma; however, its efficacy and safety as an adjuvant therapy in patients with non-metastatic and loco-regional renal cell carcinoma after surgery remains controversial. Thus, the aim of the present re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Di, Wu, Guojun, Zheng, Yu, Chen, Fubao, Lu, Jingyi, Wang, Yangmin, He, Dalin, Wang, He, Wang, Zhiping, Chen, Peng, Wang, Yujie, Wang, Zhiyong, Ye, Yongli, Zhu, Zheng, Yuan, Jianlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380792/
https://www.ncbi.nlm.nih.gov/pubmed/30702581
http://dx.doi.org/10.1097/MD.0000000000014237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380792/
https://www.ncbi.nlm.nih.gov/pubmed/30702581
http://dx.doi.org/10.1097/MD.0000000000014237

Ejemplares similares